Abstract:BACKGROUND: Cyclosporin A (CsA) is an immunosuppressant for preventing from allograft rejection. Little is known, however, about the effect of CsA on the materno-fetal relationship. OBJECTIVE: To probe into effect of CsA on the invasiveness of human first-trimester trophoblast cells, explore possible molecules involved, and provide a new therapeutic approach for pregnancy complications with trophoblast disorder. METHODS: The effects of CsA on invasion of the first-trimester human trophoblasts were examined using an invasion assay, and the transcription, translation and proteolytic activity of MMP 9 and MMP 2 in these cells were determined by RT-PCR, in-cell Western and zymography, respectively. The phosphorylation level of extracellular-signal related kinase (ERK) 1/2 in trophoblasts induced by CsA was also evaluated by in-cell Western. RESULTS: CsA significantly promoted the invasiveness of the first-trimester human trophoblast cells. The transcription, translation and proteolytic activity of MMP 9 and MMP 2 by theses cells also increased after treatment with CsA. U0126, a MEK inhibitor, remarkably inhib- ited the enhanced invasiveness and activity of MMP 9 and MMP 2 of first-trimester human trophoblast cells induced by CsA. In addition, CsA activated the ERK1/2 in a time-dependent manner. CONCLUSIONS: CsA improves the inva- siveness and activity of MMP 9 and MMP 2 in vitro of the first-trimester human trophoblast cells through activation of mitogen-activated protein kinase/extracellular-signal related kinase (ERK) 1/2 signaling pathway, which suggests this drug has a favorable modulation on the function of human first-trimester trophoblast cells.

Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via MAPK pathway